SCAPINELLO, GRETA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 484
EU - Europa 99
AS - Asia 37
OC - Oceania 3
Totale 623
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 483
IT - Italia 59
CN - Cina 28
FI - Finlandia 12
IN - India 8
GB - Regno Unito 7
DE - Germania 6
SE - Svezia 5
FR - Francia 3
NL - Olanda 3
AU - Australia 2
CA - Canada 1
IE - Irlanda 1
LU - Lussemburgo 1
NZ - Nuova Zelanda 1
RO - Romania 1
RU - Federazione Russa 1
TR - Turchia 1
Totale 623
Salva come PNG Salva come JPEG
Città #
Fairfield 102
Chandler 73
Ashburn 47
Woodbridge 37
Houston 32
Cambridge 28
Seattle 28
Padova 22
Wilmington 20
Ann Arbor 11
Helsinki 11
Medford 9
Princeton 9
San Diego 9
Beijing 8
Des Moines 6
Pune 6
Guangzhou 5
New York 4
Pignone 4
Amsterdam 3
Nanjing 3
Shanghai 3
Boardman 2
Castelfranco Veneto 2
Forlì 2
Lucknow 2
Noale 2
Ogden 2
Paris 2
Roxbury 2
Southwark 2
Sydney 2
Thiene 2
Verona 2
Adria 1
Cittadella 1
Cornedo Vicentino 1
Dublin 1
Istanbul 1
Kilburn 1
Lappeenranta 1
London 1
Luxembourg 1
New Plymouth 1
Phoenix 1
Portland 1
Prescot 1
Redwood City 1
Shenyang 1
Toronto 1
Treviso 1
Totale 521
Salva come PNG Salva come JPEG
Nome #
Splenic marginal zone lymphoma with a de novo t(8;14)(q24;q32) and a prolymphocytoid evolution responsive to rituximab-bendamustine 101
The presence of mutated and deleted PTEN is associated with an increased risk of relapse in childhood T cell acute lymphoblastic leukaemia treated with AIEOP-BFM ALL protocols 95
Ibrutinib in relapsed hairy cell leukemia variant: a case report and review of the literature 79
Protein Kinase CK1α Sustains B-Cell Receptor Signaling in Mantle Cell Lymphoma 64
Primary Pancreatic Lymphoma: Clinical Presentation, Diagnosis, Treatment and Outcome 54
A case of “double hit” mantle cell lymphoma carrying CCND1 and MYC translocations relapsed/refractory to rituximab bendamustine cytarabine (R-BAC) and ibrutinib 52
Determinants of Drug Resistance in B-Cell Non-Hodgkin Lymphomas: The Case of Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia 39
High ETV6 Levels Support Aggressive B Lymphoma Cell Survival and Predict Poor Outcome in Diffuse Large B-Cell Lymphoma Patients 36
Relevance of bone marrow histology in challenging cases of Acute Myeloid Leukemia 31
Rituximab and bendamustine (Br) compared with rituximab, bendamustine, and cytarabine (r-bac) in previously untreated elderly patients with mantle cell lymphoma 22
CK1α/RUNX2 Axis in the Bone Marrow Microenvironment: A Novel Therapeutic Target in Multiple Myeloma 21
Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies 18
Waldenström Macroglobulinemia in Very Elderly (≥75-year-old) Patients: A 33-year-retrospective Cohort Study in an Italian University Hospital 16
Protein Kinase CK2 represents a new target to boost Ibrutinib and Venetoclax induced cytotoxicity in mantle cell lymphoma 14
When Waldenström macroglobulinemia hits the kidney: Description of a case series and management of a “rare in rare” scenario 3
Impact of the presence and number of chromosomal abnormalities on the clinical outcome in Waldenström Macroglobulinemia: a monocentric experience 1
Totale 646
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.801
article - articoli 3.801
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.602
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201918 0 0 0 0 0 0 0 0 0 0 10 8
2019/202060 3 6 0 3 7 4 6 7 9 3 4 8
2020/2021115 9 7 6 33 3 4 8 12 15 3 12 3
2021/2022167 2 3 8 12 29 3 14 34 21 0 8 33
2022/2023151 24 13 8 21 28 15 0 3 23 2 5 9
2023/2024121 6 9 15 11 20 19 12 8 4 14 3 0
Totale 646